Medicine & Life Sciences
Heterografts
100%
Breast Neoplasms
70%
Triple Negative Breast Neoplasms
69%
Neoplasms
41%
Proteomics
34%
Proteogenomics
24%
Therapeutics
16%
Estrogen Receptors
15%
Growth
13%
Proteins
12%
Phosphotransferases
12%
Biomarkers
11%
Mutation
11%
Phosphatidylinositol 3-Kinases
11%
Proteome
11%
NVP-BKM120
11%
Neoplasm Metastasis
9%
Drug Therapy
9%
diptoindonesin G
8%
Ligands
8%
Peptides
8%
Phosphorylation
8%
SAR405838
8%
mirvetuximab soravtansine
7%
dinaciclib
7%
Estrogen Receptor alpha
6%
Genes
6%
Cyclin-Dependent Kinase 9
6%
Carboplatin
6%
Datasets
6%
Mass Spectrometry
6%
Proteolysis
6%
eribulin
6%
Receptor Cross-Talk
5%
Genome
5%
RNA Sequence Analysis
5%
palbociclib
5%
Workflow
5%
estrophilin
5%
Gene Fusion
5%
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
5%
Epithelial-Mesenchymal Transition
5%
Cyclin-Dependent Kinase 6
5%
ridaforolimus
5%
Checkpoint Kinase 1
5%
Phosphatidylinositol 3-Kinase
5%
Bone Marrow Diseases
5%
Receptor Protein-Tyrosine Kinases
5%
Turcot syndrome
5%
Annexin A2
5%
Chemical Compounds
Protein
15%
Mutation
11%
Resistance
8%
Estrogen
7%
RNA Sequencing
7%
Drug
6%
Peptide
6%
Oncogenic
5%
Tyrosine Kinase Inhibitor
5%